Duke University Medical Center SC-5

Durham, North Carolina 27710

We've found

2 trials

at this facility

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Status: Enrolling, Phase I
Updated: 10/18/2013

from

Durham, NC

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Durham, NC

Use our guide to learn which trials are right for you!